Preview

Regulatory Research and Medicine Evaluation

Advanced search

Differences in the pharmacokinetics of ibuprofen in monoand multi-component drugs

Abstract

The article reports the results of the study which investigated the pharmacokinetics of mono- and multi-component ibuprofen-containing drugs following single oral administration to healthy volunteers. Plasma concentration of ibuprofen was determined by HPLC with spectrophotometric detection. The main pharmacokinetic parameters - Cmax, Tmax, AUC0-t, AUC0-¥, MRT, Kel, TЅ - were calculated after single oral administration of the tested drugs. The pharmacokinetics of Ibuprofen/mono and Ibuprofen (pitofenone+fenpiverinium bromide) after single administration did not demonstrate any statistically significant differences, while the combination drug Ibuprofen/paracetamol did have statistically significant differences in pharmacokinetics as compared to the monocomponent Ibuprofen drug.

About the Authors

L. M. Krasnykh
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


V. V. Smirnov
Scientific Centre for Expert Evaluation of Medicinal Products; I. M. Sechenov First Moscow State Medical University
Russian Federation


G. F. Vasilenko
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


O. A. Goroshko
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


E. A. Egorenkov
I. M. Sechenov First Moscow State Medical University
Russian Federation


V. I. Zozina
I. M. Sechenov First Moscow State Medical University
Russian Federation


References

1. Mazaleuskaya LL, Theken KN, Gong L, Thorn CF, FitzGerald GA, Altman RB, Klein TE. PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics. 2015; 25(2): 96–106.

2. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology 2012; 78(17): 1346–53.

3. Hersh EV, Kane WT, O’Neil MG, Kenna GA, Katz NP, Golubic S, et al. Prescribing recommendations for the treatment of acute pain in dentistry. Compend Contin Educ Dent. 2011; 32(3): 24–30.

4. Brain P, Leyva R, Doyle G, Kellstein D. Onset of analgesia and efficacy of ibuprofen sodium in postsurgical dental pain. Clin J Pain. 2015; 31(5): 444–50.

5. Khalifa N, El-Husseini T, Morrah A, Mostafa E, Hamoud H. Use of ibuprofen sustained release for treating osteoarthritic pain: findings from 15 general medical practices in Egypt. Open Access Rheumatol. 2014; (6): 49–56.

6. Beaver WT. Review of the analgesic efficacy of ibuprofen. Int J Clin Pract. 2003; (135): 13–7.

7. Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice. J Int Med Res. 1988; 16(2): 83–91.

8. Baranova LN, Kupryashina NV, Lvova LV, Mazurenko DV, Morozenko OA, Muratkhuzina AR, et al. Efficacy and safety of fixed ibufprofen/paracetamol combination in fever and pain syndromes in ambulatory practice. Clinical Pharmacology and Therapy 2014; (4): 95–8 (in Russian).


Review

For citations:


Krasnykh L.M., Smirnov V.V., Vasilenko G.F., Goroshko O.A., Egorenkov E.A., Zozina V.I. Differences in the pharmacokinetics of ibuprofen in monoand multi-component drugs. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2017;7(2):117-121. (In Russ.)

Views: 1079


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)